WeedMD Secures Health Canada Approval for Six Additional Cannabis Cultivation Rooms at Modern Greenhouse

WeedMD Secures Health Canada Approval for Six Additional Cannabis Cultivation Rooms at Modern Greenhouse

(TSX-V:WMD) (OTCQX:WDDMF), a federally-licensed manufacturer and distributor of medical-grade cannabis, is pleased to announce it has secured a Health Canada licence amendment approval which allows the Company to expand production into six extra 10,000 square foot cultivation rooms at its state-of-the-art hybrid greenhouse in Strathroy, Ontario. Licensing of the six extra grow rooms, comprising a total of 60,000 sq. ft., raises WeedMD’s licensed manufacturing space in Strathroy into 110,000 sq. ft. and increases the organization ’s total manufacturing footprint, including its indoor cultivation centre-of-excellence in Aylmer, Ontario, to 136,000 sq. ft.

“This is an exciting time for WeedMD — we’ve just completed another awesome round of cannabis harvests from both sites and we’re now able to capitalize on our large-production greenhouse power expansion,” stated Keith Merker, CEO of WeedMD. “We’ve been busy preparing for this pivotal moment and have more than 20,000 cannabis plants which we will begin transplanting into the rooms instantly. With a total of 10 cultivation rooms now in operation at our state-of-the-art greenhouse, we’re responding to the considerable demand for cannabis with an efficient manufacturing ramp up so as to meet supply commitments to our patients, provincial partners, seniors care providers, Shoppers Drug Mart, and an increasing number of new patients and clients throughout the country. Additionally, we’re on the cusp of completing the fully-funded retrofit of our hybrid greenhouse expected to yield high quality, cost-effective cannabis cultivation in 2019. ”

WeedMD is well-positioned having an operational manufacturing footprint which will be greater than 500,000 sq. ft. in early 2019. For more information, access WeedMD’s investor presentation here and recently upgraded corporate video here.

About WeedMD Inc..

WeedMD Inc. is the publicly-traded parent company of WeedMD Rx Inc., a federally-licensed manufacturer and distributor of cannabis and cannabis oil for both the medical and adult-use markets under the Cannabis Act. The Company operates two facilities: a 26,000 sq. ft. indoor facility in Aylmer, Ontario and a state-of-the-art greenhouse facility located in Strathroy, Ontario. The Greenhouse now has 110,000 square feet of licensed space in production and is expected to have a total footprint of over 500,000 square feet online in early 2019. WeedMD includes a multi-channeled distribution strategy that includes supply agreements with Shoppers Drug Mart and provincial distribution agencies, as well as through strategic relationships across the seniors’ market in Canada.

LinkedIn: https://www.linkedin.com/company/weedmd/?originalSubdomain=fr
Twitter: https://twitter.com/WeedMD
Instagram: https://www.instagram.com/weedmd/

For Additional information, please contact:

WeedMD Inc..

Keith Merker, Chief Executive Officer
Tel: 519-765-2440 Ext. 222
Email: investor@weedmd.com

To find out more, visit us at www.weedmd.com

For Media Inquiries:

Marianella delaBarrera
VP, Communications & Corporate Affairs
Tel: 416-897-6644
Mail: marianella@weedmd.com

Forward Looking Information

This press release contains”forward-looking information” within the meaning of applicable Canadian securities laws which are predicated upon WeedMD’s current internal expectations, estimates, projections, assumptions and beliefs and perspectives of future events. Forward-looking information can be identified by the use of forward-looking terminology such as”expect”,”likely”,”may”,”will”,”should”,”intend”,”expect”,”possible”,”proposed”,”estimate” and other similar words, including grammatical and negative variations thereof, or statements that certain events or conditions”may”,”would” or”will” happen, or by discussions of strategy.

The forward-looking information in this news release is based upon the expectations, estimates, projections, assumptions and perspectives of future events which management considers to be reasonable in the circumstances. Forward-looking information includes quotes, plans, expectations, opinions, forecasts, projections, targets, guidance or other statements that are not statements of fact. Forward-looking information in this news release include, but are not limited to, statements with regard to internal expectations, expectations with respect to real production volumes, expectations for future growing capacity and the conclusion of any capital project or expansions. Forward-looking information necessarily involve known and unknown risks, including, without limitation, risks related to general economic conditions; adverse business events; reduction of markets; future legislative and regulatory developments; inability to access sufficient capital from internal and external resources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in Canada generally; the capability of WeedMD to execute its business plans; competition; crop failure; and other risks.

Any forward-looking information speaks only as of the date on which it is made, and, except as required by law, WeedMD does not undertake any obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise. New factors emerge from time to time, and it’s not possible for WeedMD to predict all such factors. When contemplating this forward-looking information, readers should keep in mind the risk factors and other cautionary statements in WeedMD’s Annual Information Form dated December 13, 2017 (the”AIF”) and other disclosure documents of WeedMD filed with the applicable Canadian securities regulatory authorities on SEDAR at www.sedar.com. The risk factors and other factors noted in the AIF and other disclosure documents could cause actual events or results to differ materially from those described in any forward-looking information.

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE

Released at Mon, 24 Dec 2018 12:32:34 +0000

Posted in: News

Comments are closed.